Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria

Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17897-902. doi: 10.1073/pnas.0606795103. Epub 2006 Nov 10.

Abstract

A chemical synthesis platform with broad applications and flexibility was rationally designed to inhibit biogenesis of adhesive pili assembled by the chaperone-usher pathway in Gram-negative pathogens. The activity of a family of bicyclic 2-pyridones, termed pilicides, was evaluated in two different pilus biogenesis systems in uropathogenic Escherichia coli. Hemagglutination mediated by either type 1 or P pili, adherence to bladder cells, and biofilm formation mediated by type 1 pili were all reduced by approximately 90% in laboratory and clinical E. coli strains. The structure of the pilicide bound to the P pilus chaperone PapD revealed that the pilicide bound to the surface of the chaperone known to interact with the usher, the outer-membrane assembly platform where pili are assembled. Point mutations in the pilicide-binding site dramatically reduced pilus formation but did not block the ability of PapD to bind subunits and mediate their folding. Surface plasmon resonance experiments confirmed that the pilicide interfered with the binding of chaperone-subunit complexes to the usher. These pilicides thus target key virulence factors in pathogenic bacteria and represent a promising proof of concept for developing drugs that function by targeting virulence factors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemical synthesis
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Adhesion / drug effects
  • Biofilms
  • Bridged Bicyclo Compounds* / chemical synthesis
  • Bridged Bicyclo Compounds* / pharmacology
  • Bridged Bicyclo Compounds* / therapeutic use
  • Crystallography, X-Ray
  • Drug Design*
  • Escherichia coli Proteins / chemistry
  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / metabolism
  • Escherichia coli* / drug effects
  • Escherichia coli* / pathogenicity
  • Fimbriae Proteins / genetics
  • Fimbriae Proteins / metabolism
  • Fimbriae, Bacterial* / drug effects
  • Fimbriae, Bacterial* / metabolism
  • Humans
  • Models, Molecular
  • Molecular Chaperones / chemistry
  • Molecular Chaperones / genetics
  • Molecular Chaperones / metabolism
  • Molecular Structure
  • Periplasmic Proteins / chemistry
  • Periplasmic Proteins / genetics
  • Periplasmic Proteins / metabolism
  • Point Mutation
  • Protein Conformation
  • Pyridones* / chemical synthesis
  • Pyridones* / pharmacology
  • Pyridones* / therapeutic use
  • Urinary Bladder / cytology
  • Urinary Bladder / microbiology
  • Urinary Tract Infections* / drug therapy
  • Urinary Tract Infections* / microbiology
  • Virulence Factors / antagonists & inhibitors*
  • Virulence Factors / genetics
  • Virulence Factors / metabolism

Substances

  • Anti-Bacterial Agents
  • Bridged Bicyclo Compounds
  • Escherichia coli Proteins
  • Molecular Chaperones
  • PapD protein, E coli
  • Periplasmic Proteins
  • Pyridones
  • Virulence Factors
  • Fimbriae Proteins

Associated data

  • PDB/2J7L